2-(1-octynyl)adenosine has been researched along with cardiovascular agents in 1 studies
| Studies (2-(1-octynyl)adenosine) | Trials (2-(1-octynyl)adenosine) | Recent Studies (post-2010) (2-(1-octynyl)adenosine) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 23 | 0 | 3 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Manome, Y; Marunouchi, T; Sasamori, J; Tanonaka, K; Uchibori, T | 1 |
1 other study(ies) available for 2-(1-octynyl)adenosine and cardiovascular agents
| Article | Year |
|---|---|
Effects of 2-Octynyladenosine (YT-146) on Mitochondrial Function in Ischemic/Reperfused Rat Hearts.
Topics: Adenosine; Adenosine Triphosphate; Alkynes; Animals; Cardiovascular Agents; Energy Metabolism; Heart; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Purinergic P1 Receptor Agonists; Rats, Wistar; Sodium | 2015 |